Performant Healthcare Price to Sales Ratio 2011-2024 | PHLT
Historical PS ratio values for Performant Healthcare (PHLT) over the last 10 years. The current P/S ratio for Performant Healthcare as of March 03, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Performant Healthcare P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-02-28 | 2.87 | 1.83 | |
| 2024-09-30 | 3.74 | $1.57 | 2.38 |
| 2024-06-30 | 2.90 | $1.56 | 1.86 |
| 2024-03-31 | 2.94 | $1.51 | 1.95 |
| 2023-12-31 | 3.13 | $1.50 | 2.09 |
| 2023-09-30 | 2.26 | $1.47 | 1.54 |
| 2023-06-30 | 2.70 | $1.45 | 1.87 |
| 2023-03-31 | 3.40 | $1.46 | 2.33 |
| 2022-12-31 | 3.61 | $1.51 | 2.40 |
| 2022-09-30 | 1.85 | $1.63 | 1.14 |
| 2022-06-30 | 2.63 | $1.72 | 1.53 |
| 2022-03-31 | 3.11 | $1.96 | 1.59 |
| 2021-12-31 | 2.41 | $2.15 | 1.12 |
| 2021-09-30 | 3.96 | $2.36 | 1.68 |
| 2021-06-30 | 3.75 | $2.56 | 1.46 |
| 2021-03-31 | 2.15 | $2.59 | 0.83 |
| 2020-12-31 | 0.88 | $2.87 | 0.31 |
| 2020-09-30 | 0.94 | $2.96 | 0.32 |
| 2020-06-30 | 0.65 | $2.96 | 0.22 |
| 2020-03-31 | 0.90 | $3.01 | 0.30 |
| 2019-12-31 | 1.02 | $2.82 | 0.36 |
| 2019-09-30 | 1.10 | $2.76 | 0.40 |
| 2019-06-30 | 1.05 | $2.62 | 0.40 |
| 2019-03-31 | 2.07 | $2.55 | 0.81 |
| 2018-12-31 | 2.25 | $2.96 | 0.76 |
| 2018-09-30 | 2.12 | $2.86 | 0.74 |
| 2018-06-30 | 2.15 | $2.92 | 0.74 |
| 2018-03-31 | 3.00 | $3.02 | 0.99 |
| 2017-12-31 | 1.65 | $2.61 | 0.63 |
| 2017-09-30 | 1.82 | $2.63 | 0.69 |
| 2017-06-30 | 2.09 | $2.67 | 0.78 |
| 2017-03-31 | 2.93 | $2.71 | 1.08 |
| 2016-12-31 | 2.35 | $2.81 | 0.84 |
| 2016-09-30 | 2.95 | $2.97 | 0.99 |
| 2016-06-30 | 1.62 | $3.13 | 0.52 |
| 2016-03-31 | 1.70 | $3.20 | 0.53 |
| 2015-12-31 | 1.79 | $3.22 | 0.56 |
| 2015-09-30 | 2.42 | $3.18 | 0.76 |
| 2015-06-30 | 3.24 | $3.21 | 1.01 |
| 2015-03-31 | 3.40 | $3.54 | 0.96 |
| 2014-12-31 | 6.65 | $3.94 | 1.69 |
| 2014-09-30 | 8.08 | $4.36 | 1.85 |
| 2014-06-30 | 10.10 | $5.10 | 1.98 |
| 2014-03-31 | 9.05 | $5.34 | 1.69 |
| 2013-12-31 | 10.30 | $5.17 | 1.99 |
| 2013-09-30 | 10.90 | $5.13 | 2.12 |
| 2013-06-30 | 11.59 | $4.70 | 2.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.193B | $0.114B |
| Performant Financial Corporation is engaged in providing technology-enabled recovery and related analytics services in the United States. The company's services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients. Services offered by the company includes financial asset recovery, risk management, audit and recovery cost containment and fraud, waste and abuse marketplace. Performant provides its services on an outsourced basis. It provides services to clients in a range of different markets which includes student lending and healthcare, delinquent state taxes and federal Treasury and other receivables. Performant Financial Corporation is headquartered in Livermore, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |